Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 9/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.45 |
| ▸ | MPC2 | O95563 | 1/20 | 0.41 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19559701 | 0.91 | PPARG (0.51) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL19217795 | 0.91 | PPARG (0.53) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL19217570 | 0.85 | PPARG (0.68) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL6928116 | 0.83 | PPARG (0.72) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL6928538 | 0.83 | PPARG (0.72) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL14213631 | 0.83 | PPARG (0.51) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL14213648 | 0.83 | PPARG (0.51) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL19559673 | 0.82 | PPARG (0.52) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL19559664 | 0.82 | PPARG (0.42) | PPARGFFAR1MPC2CYP2C8CYP2C9 | |
| SCHEMBL19559725 | 0.81 | PPARG (0.40) | PPARGFFAR1CYP2C9MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2513070-B1 | PPAR-SPARING THIAZOLIDINEDIONE SALTS FOR THE TREATMENT OF METABOLIC DISEASES | CIRIUS THERAPEUTICS INC (US) | 2017-11-08 | — | — | EP | disclosed |